SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling
Martin Puhr(Innsbruck Medical University), Zoran Čulig(Innsbruck Medical University)
Cited by 41
Related Papers
Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours
|Endocrine Related Cancer|2005|94
Suppressor of Cytokine Signaling (SOCS)-1 Is Expressed in Human Prostate Cancer and Exerts Growth-Inhibitory Function through Down-Regulation of Cyclins and Cyclin-Dependent Kinases
|American Journal Of Pathology|2009|67
Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways
|Endocrine Related Cancer|2012|65
Suppressor of Cytokine Signaling-3 Antagonizes cAMP Effects on Proliferation and Apoptosis and Is Expressed in Human Prostate Cancer
|American Journal Of Pathology|2006|59
p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancer
|Endocrine Related Cancer|2020|28